Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Endocrinology | Family Medicine | Internal Medicine | Pathology | Pediatrics | Journal

Back to Journal Articles

Ten New Susceptibility Loci Identified for Type 2 Diabetes

Last Updated: August 16, 2012.

 

Meta-analysis of genetic variants on the Metabochip ID'd loci, two of which are sex-linked

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Using a new DNA chip, the Metabochip, which includes 196,725 variants, to identify nominal associations for type 2 diabetes (T2D) and other metabolic and cardiovascular traits, 10 novel loci have been identified for T2D, according to research published online Aug. 12 in Nature Genetics.

THURSDAY, Aug. 16 (HealthDay News) -- Using a new DNA chip, the Metabochip, which includes 196,725 variants, to identify nominal associations for type 2 diabetes (T2D) and other metabolic and cardiovascular traits, 10 novel loci have been identified for T2D, according to research published online Aug. 12 in Nature Genetics.

To extend the identification and characterization of variants influencing T2D susceptibility, Andrew P. Morris, Ph.D., from the University of Oxford in the United Kingdom, and colleagues used the Metabochip, which comprises 21,774 variants in the T2D component, to conduct a meta-analysis of genetic variants in a sample including 34,840 cases and 114,981 controls, mainly of European descent.

The researchers identified 10 novel susceptibility loci, which were previously unreported. Two of these showed sex-differentiated associations.

"The data support the view that much of the overall variance in T2D susceptibility can be attributed to the impact of a large number of common causal variants, most of very modest effect," the authors write. "Although such a model poses challenges for accumulating genome-wide significant evidence of association at a specific variant, it does suggest that genetic profiling of the entirety of sequence variation has the potential to provide useful risk stratification for T2D."

Several authors disclosed financial ties to the pharmaceutical industry and to deCODE Genetics.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Brain's 'Glymphatic' System Clears Interstitial Solutes Next: Sedentary Behavior Linked to Motor Coordination in Children

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.